688176.SHG Jiangsu Yahong Meditech Co. Ltd.

Healthcare Pharmaceuticals Shanghai Stock Exchange
11.20 CNY
Close of Nov 4, 2026
8.93 18.11
Market cap
CNY 6.41B
P/E
-
P/B
4.93x
ROE
-39.2%
Dividend yield
0.06%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688176.SHG undervalued?

Graham number

The Graham number of Jiangsu Yahong Meditech Co. Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Jiangsu Yahong Meditech Co. Ltd. fundamental analysis

No fundamental analysis for Jiangsu Yahong Meditech Co. Ltd. yet.

Jiangsu Yahong Meditech Co. Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Jiangsu Yahong Meditech Co. Ltd.

Jiangsu Yahong Meditech Co., Ltd., a pharmaceutical company, focuses on urogenital tumors and women's health in China and internationally. It develops APL-1702, a photodynamic drug-device combination product for the treatment of high-grade squamous intraepithelial lesions of the cervix and for HPV viral clearance; APL-2302, an oral small-molecule inhibitor of the deubiquitinating enzyme ubiquitin-specific protease 1 (USP1) for the treatment of ovarian and breast cancer; APL-…

Full company profile